Antibody Technologies Market Research Reports & Industry Analysis
Antibody technologies involve the use of specialized proteins called antibodies to target and detect specific molecules, often used in medical diagnostics, therapeutics, and research. This field is evolving quickly due to scientific advancements and the growing demand for personalized treatments. To help you stay updated on the latest developments, MarketResearch.com offers a comprehensive collection of reports on antibody technologies.
Valuable Antibody Technologies Research and Analysis
- Find detailed data on various market segments including precision medicine, biosimilars, biologics, protein engineering, and more.
- Obtain antibody technologies market sizing and growth projections, discussions of key drivers and challenges, pricing and regulatory analysis, and company profiles.
- Read expert commentary on recent technological innovations and industry trends to gain a clear understanding of emerging opportunities.
Your Research Partner
Whether you're an experienced industry professional, a consultant, or a busy executive, our antibody technologies market research reports are designed to help you make informed decisions. With reliable data and thorough analyses, these reports support your decision-making process. By choosing MarketResearch.com, you can gain the intelligence needed to stay competitive and take advantage of new opportunities.
Antibody Technologies Industry Research & Market Reports
-
Plasma Protein Therapeutics Market Report 2022-2032
... and Middle Income Countries Due to the worldwide initiatives, a rise in voluntary, unpaid blood donations from low- and middle-income countries has been noted to fulfil the unmet need for red blood cell concentrates. In ... Read More
-
Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2027
... for the detailed examination of biological and biotechnology products. Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services ... Read More
-
Graft Versus Host Disease Market By Product Type (Corticosteroids, Monoclonal antibodies, Immunosuppressants, Others), By Treatment Type (Acute GVHD, Chronic GVHD), By End Use (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031
... 2021-2031 The global Graft Versus Host Disease Market was valued at $2,968.6 million in 2021, and is projected to reach $10,375.3 million by 2031, registering a CAGR of 13.5% from 2022 to 2031. Graft versus ... Read More
-
2022 Global Forecast for Anti-Osteocalcin Antibody Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Global Next-Generation Antibody Therapeutics Market: Market Segments: By Therapeutic Area (Oncology Autoimmune/Inflammatory); By Technology (Antibody-Drug Conjugates (ADCs), Bispecific Antibodies, Fc-engineered Antibodies, Antibody Fragments and Antibody-like Proteins & Biosimilar Antibody Products);and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030
... Size, Share & Trends for 2014 – 2019 and Forecasts to 2030 Product Overview Use of a new improvised therapeutic antibody to form novel medicines for the treatment of different diseases includes next-generation antibody therapeutics. ... Read More
-
2022 Global Forecast for Antibody Library Technology Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales ... Read More
-
2022 Global Forecast for Anti-Thyroglobulin Antibody Test Kit Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material ... Read More
-
2022 Global Forecast for Antibodies Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
2022 Global Forecast for Anti-Versican Antibody Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
2022 Global Forecast for Anti-Tnf-A Monoclonal Antibody Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales ... Read More
-
2022 Global Forecast for Anti-Thyroid Peroxidase Antibody Test Kit Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... over 50 countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or ... Read More
-
Therapeutic Proteins and Oral Vaccines Market, by Drug Class (Therapeutic Proteins (Growth Factors, Fusion Proteins, Monoclonal Antibodies, Hormones, Coagulation Factors, and Others) and Oral Vaccines (Live Attenuated Vaccine, Inactivated Vaccine, Recombi
... Application (Oncology, Hematology, Immunology, Endocrinology, Infectious Disease, Cardiovascular Disease, and Others), by Distribution Channel Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) ... Read More
-
Europe Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application (Breast Cancer, Blood Cancer, Urothelial Cancer & Bladder Cancer, and Others), By Technology, By Country and Growth Forecast, 2022 - 2028
... The Europe Antibody Drug Conjugates Market would witness market growth of 13.8% CAGR during the forecast period (2022-2028). Antigens expressed predominantly on the surface of tumor cells are ideal targets for ADCs. Hematological malignancies express ... Read More
-
Sterile Injectables Market, by Molecule Type (Large Molecule and Small Molecule), by Drug Type (Monoclonal Antibodies (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulins, Blood Factors, Peptide Antibiotics, and Others), by Therapeutic
... Cardiovascular Diseases, Central Nervous Systems Disorders, Infectious Disorders, Musculoskeletal Disorders, and Others), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and ... Read More
-
North America Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application (Breast Cancer, Blood Cancer, Urothelial Cancer & Bladder Cancer, and Others), By Technology, By Country and Growth Forecast, 2022 – 2028
... 2028 The North America Antibody Drug Conjugates Market would witness market growth of 13.7% CAGR during the forecast period (2022-2028). ADCs are anticancer medications that are one of the quickest treatments for cancer patients, with ... Read More
-
Global Antibody Drug Conjugates Market Size, Share & Industry Trends Analysis Report By Application (Breast Cancer, Blood Cancer, Urothelial Cancer & Bladder Cancer, and Others), By Technology, By Regional Outlook and Forecast, 2022 – 2028
... The Global Antibody Drug Conjugates Market size is expected to reach $13.8 billion by 2028, rising at a market growth of 14.2% CAGR during the forecast period. Antibody Drug Conjugates (ADCs) are biopharmaceutical drugs that ... Read More
-
Coronavirus Treatment Drugs Market, by Drug Class (Corticosteroids, Anti-viral, Monoclonal Antibodies, Kinase Inhibitors, and Others), by Route of Administration (Oral and Intravenous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and
... (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 The coronavirus treatment drugs comprises therapeutics which are used for treatment of the novel ... Read More
-
U.S. Sterile Injectables Market, by Molecule Type (Large Molecule and Small Molecule), by Drug Type (Monoclonal Antibody (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulin’s, Blood Factors, Peptide Antibiotics, and Others), by Therapeu
... Diseases, Cardiovascular Diseases, Central Nervous System Disorder, Infectious Diseases, Musculoskeletal Disorders, and Others), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online ... Read More
-
Intravenous Immunoglobulin Market (Indication: Chronic Inflammatory Demyelinating Polyneuropathy, Primary Humoral Immunodeficiency, Idiopathic Thrombocytopenic Purpura, Guillain-Barre Syndrome, Myasthenia Gravis, Multifocal Motor Neuropathy, Kawasaki Disease, Hypogammaglobulinemia, Chronic Lymphocytic Leukemia, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... Growth, Trends, and Forecast, 2022-2031 Companies Mentioned Baxalta Incorporated Biotest AG China Biologic Products, Inc. CSL Behring LLC Grifols S.A. Kedrion S.p.A. LFB Biomedicaments S.A. Octapharma AG Sanquin Plasma Products B.V." Countries North America Europe ... Read More
-
India Immuno-Oncology Drugs Market, by Drug Type (Immune Checkpoint Inhibitors (Nivolumab, Atezolimumab, Pembrolizumab, Durvalumab), Monoclonal Antibodies (Rituximab, Trastazumab, Bevacizumab , Nimotuzumab, Pertuzumab, Ado-Trastuzumab Emtansine ), and Can
... Blood Cancer, Breast Cancer, Ovarian Cancer, Cervical Cancer, Colorectal Cancer, Stomach Cancer, Head & Neck Cancer, and Others), and by Distribution Channel (Online Pharmacies, Retail Pharmacies, and Hospital Pharmacies) - Size, Share, Outlook, and Opportunity ... Read More
-
Immunology Market, by Drug Class (Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody (pAb), and Others), by Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammat
... Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 ... Read More
-
Targeted Therapy Market, by Type (Small Molecule Medicines and Monoclonal Antibodies), by Application (Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharm
... and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Targeted therapy is used individually and in combination with other treatments, ... Read More
-
Global Research Antibodies Market 2022-2028
... research, diagnostic tests and theraputics. As a cornerstone of the body's immune response, antibodies can provide significant data to support scientists' research. The global research antibodies market is anticipated to reach valuation of ~USD 4,892 ... Read More
-
Global Neuroscience Antibodies and Assays Market - 2022-2029
... 2029, growing at a CAGR of XX % during the forecast period (2022-2029). Antibodies are used extensively in neuroscience research to help identify and elucidate reactions at the cellular, molecular, and biochemical levels, leading to ... Read More
-
Global Guillain-Barre Syndrome Treatment Market - 2022-2029
... at a CAGR of XX % during the forecast period (2022-2029). Guillain-Barre syndrome (GBS), also known as Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP), is an acute disorder marked by paralysis of limbs, difficulty breathing moving the ... Read More
Research Assistance
